Promising new finding for therapies to treat persistent seizures in epileptic patients

LA BioMed researcher says study identified new potential site for medications to target

2013-01-16

(Press-News.org) LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain.

"Despite the development of new medications to prevent seizures, status epilepticus remains a life-threatening condition that can cause extensive brain damage in the patients that survive these persistent seizures," said David E. Naylor, MD, PhD, a lead researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and corresponding author of the new study. "Our research holds promise for the development of new therapies to treat this devastating condition because we have found a potential new target for medical intervention that should bolster the current standard therapies to treat the acute seizures. It may also prevent the long-term adverse effects of persistent seizure activity on the brain."

The research, reported online in the Neurology of Disease journal, used animal models to assess cellular activity in the brain during persistent seizures. It found that the seizure activity seemed to force the NMDA receptors from the interior to the surface of nerve cells causing their activity to increase by approximately 38%.

"The increased presence of the NMDA receptors on the cell surface during these seizures may explain the successful use of NMDA antagonists – medication that inhibits the activity of the NMDA receptors in the brain – in the latter stages of a seizure, long after other medications have stopped working," said Dr. Naylor. "We concluded that medications that suppress the activity of the NMDA receptors, in conjunction with other medications, may be successful in stopping persistent seizures. Further research is, of course, needed."

INFORMATION:

In addition to Dr. Naylor, the researchers who participated in the study were Drs. Hantao Liu at the Veterans Administration Greater Los Angeles County Healthcare System's Department of Neurology and Jerome Niquet and Claude G. Wasterlain of the David Geffen School of Medicine at the University of California, Los Angeles Department of Neurology. The research was funded by LA BioMed and a Veterans Administration Career Development Award. The study may be viewed online at http://www.sciencedirect.com/science/article/pii/S0969996113000065

About LA BioMed

Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and therapies for chronic diseases, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.labiomed.org.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Using snail teeth to improve solar cells and batteries

2013-01-16

RIVERSIDE, Calif. (www.ucr.edu) — An assistant professor at the University of California, Riverside's Bourns College of Engineering is using the teeth of a marine snail found off the coast of California to create less costly and more efficient nanoscale materials to improve solar cells and lithium-ion batteries. The most recent findings by David Kisailus, an assistant professor of chemical and environmental engineering, details how the teeth of chiton grow. The paper was published today (Jan. 16) in the journal Advanced Functional Materials. It was co-authored by several ...

Developed new method to diagnose hereditary breast and ovarian cancer

2013-01-16

Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective. The new protocol has been described in an article published in the European Journal of Human Genetics. In recent years, new advances in sequencing techniques have involved the development of new platforms for nucleic ...

Dynamic Motivational Author, Speaker & Veteran Deborah L. Parker Keynotes Leesburg Virginia's Martin Luther King March & Program, "Moving the Dream Forward For All of Us" January 21

2013-01-16

Deborah L. Parker remembers the evening of April 4, 1968. In her rural Waverly Virginia home with no indoor plumbing, on the way to the laundromat with her mother, it seemed as if the world stopped. The headline of the evening news: Dr. Martin Luther King Jr. has been assassinated. What happens to the dream? Deborah wondered. She was poor, black, and a good student in a segregated Sussex County. Her mother was a single parent of four and they lived with her maternal grandparents in a shotgun style house on a wooded back road. But her mother was determined and her grandparents ...

Migraine with aura may lead to heart attack, blood clots for women

2013-01-16

SAN DIEGO – Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The first study showed that migraine with aura is a strong contributor to the development of major cardiovascular events such as heart attack and stroke. The Women's ...

Higher quality rating for Medicare Advantage plan linked with increased likelihood of enrollment

2013-01-16

CHICAGO – In a study that included nearly 1.3 million Medicare beneficiaries who were either first-time enrollees or enrollees switching plans, researchers found a positive association between enrollment and publicly reported Medicare Advantage star ratings reflecting plan quality, according to a study appearing in the January 16 issue of JAMA. "To inform enrollment decisions and spur improvement in the Medicare Advantage marketplace, the U.S. Centers for Medicare & Medicaid Services (CMS) provides star ratings reflecting Medicare Advantage plan quality. A combined Part ...

Transmission of tangles in Alzheimer's mice provides more authentic model of tau pathology

2013-01-16

PHILADELPHIA – Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments. Tau tangles are also found in progressive supranuclear palsy, cortical basal degeneration and other related tauopathies, including chronic traumatic encephalopathy due to repetitive traumatic brain injuries sustained in sports or on the battle field. By using synthetic fibrils made from pure recombinant protein, Penn ...

Tracing the impact of amyloid beta in mild cognitive impairment

2013-01-16

The amount of amyloid β (Aβ) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's open access journal Alzheimer's Research & Therapy. The non-invasive study which used 18F-florbetaben to find Aβ plaques in brain scans to also show that in MCI the affect of Aβ on memory loss is independent of other aspects of mental decline. Positron emission tomography (PET) has previously relied on carbon-11 labeling of Aβ, however this ...

Cutting down on sugar has a small but significant effect on body weight

2013-01-16

Research: Dietary sugars and body weight: a systematic review and meta-analyses of randomised controlled trials and cohort studies Editorial: Science souring on sugar Feature: Sugar and the heart: old ideas revisited Reducing sugar intake has a small but significant effect on body weight in adults, finds a paper published on bmj.com today. Although the effect is relatively small (an average reduction of 0.8 kg), the findings provide some support for international guidelines to cut sugar intake to less than 10% of total energy to help reduce the global obesity epidemic. Excessive ...

Blood clots and artery blockage more likely during IVF pregnancies

2013-01-16

Research: Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study In vitro fertilization (IVF) is associated with an increased risk of pulmonary embolism (blockage of the main artery of the lung) and venous thromboembolism (blood clots) during the first trimester of pregnancy, a study published today on bmj.com suggests. IVF has been used since 1978 for the 10% of couples worldwide affected by infertility. Approximately five million individuals have so far been born after IVF. It is well known that the ...

Virtual heart sheds new light on heart defect

2013-01-16

A virtual heart, developed at The University of Manchester, is revealing new information about one of the world's most common heart conditions. Researchers at the School of Physics and Astronomy used cutting edge technology to build an advanced computational model of an anatomically correct sheep's heart. It was made by taking a series of very thin slices of the heart, imaging them in 2D and then using a computer programme to render them into a 3D model. The reconstruction includes details of the complex fibre structure of the tissue, and the segmentation of the upper ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Promising new finding for therapies to treat persistent seizures in epileptic patients

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: